IMVT

IMVT Stock-Based Compensation

$50.99MTTM · USD

Period ending:

IMVT FY Stock-Based CompUSD
IMVT FY Stock-Based Comp2018-03-31: $1.81M2019-03-31: $1.31M2020-03-31: $6.96M2021-03-31: $0.002022-03-31: $34.24M2023-03-31: $32.30M2024-03-31: $41.12M2025-03-31: $49.49M2026-03-31: $55.72M$55.72M$0.00
2018-03-312026-03-31

Source: Financial Modeling Prep (FMP). Annual fiscal periods; reported in USD. Dates are period ends; a fiscal year may differ from a calendar year.

IMVT stock-based compensation history

Non-cash compensation expense paid in equity. The available annual fiscal periods series contains 9 observations from Mar 31, 2018 to Mar 31, 2026.

Immunovant Inc Stock-Based Compensation — Annual fiscal periods (USD)
Period endingStock-Based Compensation (USD)
55,724,000
49,487,000
41,116,000
32,296,000
34,244,000
0
6,963,000
1,308,000
1,812,488

Compare stock-based compensation

All IMVT financial metrics · IMVT stock overview · How to interpret financial metrics

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.